NCT02985762View on ClinicalTrials.gov

PK Study of EXPAREL in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Spinal FusionPain Management
Interventions
DRUG

EXPAREL

Trial Locations (3)

19107

Thomas Jefferson University, Philadelphia

33136

University of Miami, Miami

43210

The Ohio State University Wexner Medical Center, Columbus

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT02985762 - PK Study of EXPAREL in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery | Biotech Hunter | Biotech Hunter